AVANOS MED INC's ticker is AVNS and the CUSIP is 05350V106. A total of 279 filers reported holding AVANOS MED INC in Q4 2022. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $597,000 | +52.3% | 27,358 | +133.8% | 0.01% | +25.0% |
Q1 2022 | $392,000 | -83.0% | 11,700 | -83.2% | 0.00% | -90.9% |
Q3 2020 | $2,310,000 | -40.8% | 69,544 | -47.6% | 0.04% | -15.4% |
Q2 2020 | $3,904,000 | -51.7% | 132,804 | -44.6% | 0.05% | -73.6% |
Q4 2019 | $8,080,000 | +13.3% | 239,772 | +130.3% | 0.20% | -37.9% |
Q3 2018 | $7,131,000 | – | 104,100 | – | 0.32% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Paradice Investment Management LLC | 2,272,758 | $45,955,167 | 3.94% |
RGM Capital, LLC | 2,951,691 | $59,683,192 | 2.73% |
Tributary Capital Management, LLC | 707,122 | $14,298,007 | 1.35% |
HEARTLAND ADVISORS INC | 573,095 | $12,775,623 | 0.72% |
WESTWOOD HOLDINGS GROUP INC | 2,109,273 | $42,650 | 0.40% |
Foundry Partners, LLC | 212,556 | $4,297,882 | 0.27% |
Keene & Associates, Inc. | 13,675 | $276,509 | 0.22% |
J. Goldman & Co LP | 231,132 | $4,673,489 | 0.16% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 307,778 | $6,223,271 | 0.15% |
Invenomic Capital Management LP | 155,936 | $3,153,026 | 0.13% |